作者搜索结果

1

Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital‐Based Towards Home‐Sampling 由 Marinda Meertens, Hilde Rosing, Neeltje Steeghs, Jos H. Beijnen, Alwin D. R. Huitema

出版 2025

获取全文
Revisão

加到收藏夹

Saved in:
2

Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz 由 W. Kromdijk, Jan W. Mulder, Hilde Rosing, Patrick M. Smit, Jos H. Beijnen, Alwin D. R. Huitema

出版 2012

获取全文获取全文
Artigo

加到收藏夹

Saved in:
3

Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma 由 Julie M. Janssen, Niels de Vries, Nikkie Venekamp, Hilde Rosing, Alwin D. R. Huitema, Jos H. Beijnen

出版 2019

获取全文
Artigo

加到收藏夹

Saved in:
4

Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples 由 Anke E Kip, K. Kiers, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Thomas P. C. Dorlo

出版 2016

获取全文
Artigo

加到收藏夹

Saved in:
5

Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liqu... 由 Alejandra Martínez-Chávez, Hilde Rosing, M. J. X. Hillebrand, Matthijs M. Tibben, Alfred H. Schinkel, Jos H. Beijnen

出版 2019

获取全文获取全文
Artigo

加到收藏夹

Saved in:
6

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel 由 Jeroen J. M. A. Hendrikx, Jurjen S. Lagas, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Alfred H. Schinkel

出版 2012

获取全文获取全文
Artigo

加到收藏夹

Saved in:
7

Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B<sub>2</sub>) into Milk 由 Antonius E. van Herwaarden, Els Wagenaar, Gracia Merino, Johan W. Jonker, Hilde Rosing, Jos H. Beijnen, Alfred H. Schinkel

出版 2006

获取全文
Artigo

加到收藏夹

Saved in:
8

Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor 由 Jaap Verweij, Birthe Lund, Jos H. Beijnen, A. S. T. Planting, M de Boer-Dennert, I. Koier, Hilde Rosing, H. Hansen

出版 1993

获取全文
Artigo

加到收藏夹

Saved in:
9

Development and validation of a rapid and sensitive UPLC–MS/MS method for determination of uracil and dihydrouracil in human plasma 由 Bart Jacobs, Hilde Rosing, Niels de Vries, Didier Meulendijks, Linda M. Henricks, Jan H.M. Schellens, Jos H. Beijnen

出版 2016

获取全文
Artigo

加到收藏夹

Saved in:
10

Quantification of 11 Therapeutic Kinase Inhibitors in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography Coupled With Tandem Mass Spectrometry 由 Maikel Herbrink, Niels de Vries, Hilde Rosing, Alwin D. R. Huitema, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen

出版 2016

获取全文
Artigo

加到收藏夹

Saved in:
11

Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation 由 Jeroen J. M. A. Hendrikx, Jurjen S. Lagas, Els Wagenaar, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Alfred H. Schinkel

出版 2014

获取全文获取全文
Artigo

加到收藏夹

Saved in:
12

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor 由 JHM Schellens, G.J. Creemers, Jos H. Beijnen, Hilde Rosing, M de Boer-Dennert, Mirna McDonald, B. E. Davies, Jaap Verweij

出版 1996

获取全文
Artigo

加到收藏夹

Saved in:
13

Human OATP1B1, OATP1B3 and OATP1A2 can mediate the<i>in vivo</i>uptake and clearance of docetaxel 由 Dilek Iusuf, Jeroen J. M. A. Hendrikx, Anita van Esch, Evita van de Steeg, Els Wagenaar, Hilde Rosing, Jos H. Beijnen, Alfred H. Schinkel

出版 2014

获取全文获取全文
Artigo

加到收藏夹

Saved in:
14

Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients 由 Mirte M. Malingré, Jos H. Beijnen, Hilde Rosing, F J Koopman, Roxanne C. Jewell, Elaine Paul, W.W. ten Bokkel Huinink, Jan H.M. Schellens

出版 2001

获取全文获取全文
Artigo

加到收藏夹

Saved in:
15

Development and validation of ultra-performance liquid chromatography tandem mass spectrometry methods for the quantitative analysis of the antiparasitic drug DNDI-6148 in human pl... 由 Wietse M. Schouten, Katrien Van Bocxlaer, Hilde Rosing, Alwin D. R. Huitema, Jos H. Beijnen, Jadel M. Kratz, Charles E. Mowbray, Thomas P. C. Dorlo

出版 2024

获取全文
Artigo

加到收藏夹

Saved in:
16

Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study 由 Wietse M. Schouten, Katrien Van Bocxlaer, Hilde Rosing, Alwin D. R. Huitema, Jos H. Beijnen, Jadel M. Kratz, Charles E. Mowbray, Thomas P. C. Dorlo

出版 2025

获取全文
Artigo

加到收藏夹

Saved in:
17

Validated LC‐MS/MS Method for Quantifying the Antiparasitic Nitroimidazole DNDI‐0690 in Preclinical Target Site PK/PD Studies 由 Wietse M. Schouten, Katrien Van Bocxlaer, Hilde Rosing, Alwin D. R. Huitema, Jos H. Beijnen, Jadel M. Kratz, Charles E. Mowbray, Thomas P. C. Dorlo

出版 2025

获取全文
Artigo

加到收藏夹

Saved in:
18

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. 由 Manon Huizing, Anther Keung, Hilde Rosing, V van der Kuij, W.W. ten Bokkel Huinink, I. Mandjes, Anne-Charlotte Dubbelman, Herbert M. Pinedo, Jos H. Beijnen

出版 1993

获取全文
Artigo

加到收藏夹

Saved in:
19

Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks 由 L.J.C. van Warmerdam, Jaap Verweij, Jan H.M. Schellens, Hilde Rosing, Brian E. Davies, M de Boer-Dennert, R. A. A. Maes, J. H. Beijnen

出版 1995

获取全文
Artigo

加到收藏夹

Saved in:
20

Exposure–Response Analyses of Anaplastic Lymphoma Kinase Inhibitors Crizotinib and Alectinib in Non‐Small Cell Lung Cancer Patients 由 Stefanie L. Groenland, Dieuwertje R. Geel, Julie M. Janssen, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Jacobus A. Burgers, Egbert F. Smit, Alwin D. R. Huitema, Neeltje Steeghs

出版 2020

获取全文获取全文
Artigo

加到收藏夹

Saved in:

检索结果 - Hilde Rosing

Advancing Therapeutic Drug Monitoring for Oral Targeted Anticancer Drugs: From Hospital‐Based Towards Home‐Sampling 由 Marinda Meertens, Hilde Rosing, Neeltje Steeghs, Jos H. Beijnen, Alwin D. R. Huitema

Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz 由 W. Kromdijk, Jan W. Mulder, Hilde Rosing, Patrick M. Smit, Jos H. Beijnen, Alwin D. R. Huitema

Development and validation of a liquid chromatography-tandem mass spectrometry assay for nine oral anticancer drugs in human plasma 由 Julie M. Janssen, Niels de Vries, Nikkie Venekamp, Hilde Rosing, Alwin D. R. Huitema, Jos H. Beijnen

Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples 由 Anke E Kip, K. Kiers, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Thomas P. C. Dorlo

P‐glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel 由 Jeroen J. M. A. Hendrikx, Jurjen S. Lagas, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Alfred H. Schinkel

Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B<sub>2</sub>) into Milk 由 Antonius E. van Herwaarden, Els Wagenaar, Gracia Merino, Johan W. Jonker, Hilde Rosing, Jos H. Beijnen, Alfred H. Schinkel

Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor 由 Jaap Verweij, Birthe Lund, Jos H. Beijnen, A. S. T. Planting, M de Boer-Dennert, I. Koier, Hilde Rosing, H. Hansen

Development and validation of a rapid and sensitive UPLC–MS/MS method for determination of uracil and dihydrouracil in human plasma 由 Bart Jacobs, Hilde Rosing, Niels de Vries, Didier Meulendijks, Linda M. Henricks, Jan H.M. Schellens, Jos H. Beijnen

Quantification of 11 Therapeutic Kinase Inhibitors in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography Coupled With Tandem Mass Spectrometry 由 Maikel Herbrink, Niels de Vries, Hilde Rosing, Alwin D. R. Huitema, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen

Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation 由 Jeroen J. M. A. Hendrikx, Jurjen S. Lagas, Els Wagenaar, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Alfred H. Schinkel

Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor 由 JHM Schellens, G.J. Creemers, Jos H. Beijnen, Hilde Rosing, M de Boer-Dennert, Mirna McDonald, B. E. Davies, Jaap Verweij

Human OATP1B1, OATP1B3 and OATP1A2 can mediate the<i>in vivo</i>uptake and clearance of docetaxel 由 Dilek Iusuf, Jeroen J. M. A. Hendrikx, Anita van Esch, Evita van de Steeg, Els Wagenaar, Hilde Rosing, Jos H. Beijnen, Alfred H. Schinkel

Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients 由 Mirte M. Malingré, Jos H. Beijnen, Hilde Rosing, F J Koopman, Roxanne C. Jewell, Elaine Paul, W.W. ten Bokkel Huinink, Jan H.M. Schellens

Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study 由 Wietse M. Schouten, Katrien Van Bocxlaer, Hilde Rosing, Alwin D. R. Huitema, Jos H. Beijnen, Jadel M. Kratz, Charles E. Mowbray, Thomas P. C. Dorlo

Validated LC‐MS/MS Method for Quantifying the Antiparasitic Nitroimidazole DNDI‐0690 in Preclinical Target Site PK/PD Studies 由 Wietse M. Schouten, Katrien Van Bocxlaer, Hilde Rosing, Alwin D. R. Huitema, Jos H. Beijnen, Jadel M. Kratz, Charles E. Mowbray, Thomas P. C. Dorlo

Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. 由 Manon Huizing, Anther Keung, Hilde Rosing, V van der Kuij, W.W. ten Bokkel Huinink, I. Mandjes, Anne-Charlotte Dubbelman, Herbert M. Pinedo, Jos H. Beijnen

Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks 由 L.J.C. van Warmerdam, Jaap Verweij, Jan H.M. Schellens, Hilde Rosing, Brian E. Davies, M de Boer-Dennert, R. A. A. Maes, J. H. Beijnen

检索工具:

相关主题